Drug intelligence / Profile preview

TriSTAR0703

Development stage
Preclinical
Lead developer
Marengo Therapeutics
Modality
Trispecific Antibodies → Multispecific Antibodies → Engineered Antibody Formats → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

TriSTAR0703 is a trispecific antibody being developed by Marengo Therapeutics for the treatment of various oncology indications. It is built upon the proprietary TriSTAR (Trispecific T Cell Engager) platform, which is designed to selectively activate and expand a specific pool of memory Vβ T cells. Unlike traditional T cell engagers that can lead to T cell exhaustion, the TriSTAR platform aims to redirect highly potent memory T cells to the tumor microenvironment, specifically targeting 'cold' tumors that are typically resistant to standard immunotherapies. TriSTAR0703 is currently a partnered program, although the specific molecular targets and the identity of the partner have not been publicly disclosed.

02

Targets

CD28 (Cluster of Differentiation 28)TRBV (T-cell receptor beta variable chain family)MAGEA8 (Melanoma-associated antigen 8)γδ TCR (T-cell receptor)

Beyond the preview

Go deeper on TriSTAR0703.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TriSTAR0703.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call